Vivoryon Therapeutics NV (VVY) — Strategic Asset Allocation Index
Vivoryon Therapeutics NV (VVY) has a Strategic Asset Allocation Index of 0.3% as of June 2023. Strategic assets (PP&E of €126.00K plus long-term investments of €-) total €126.00K, measured against net assets of €41.53 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Vivoryon Therapeutics NV Strategic Asset Allocation Index (2016–2022)
This chart shows how Vivoryon Therapeutics NV's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 0.3%, representing strategic assets of €126.00K against net assets of €41.53 Million EUR. Explore Vivoryon Therapeutics NV (VVY) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Vivoryon Therapeutics NV (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Vivoryon Therapeutics NV from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see VVY stock market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.7% | €176.00K | €176.00K | €- | €26.51 Million | ▼ -1.1 pp |
| 2021 | 1.7% | €285.00K | €285.00K | €- | €16.56 Million | ▲ +0.2 pp |
| 2020 | 1.5% | €390.00K | €390.00K | €- | €26.22 Million | ▲ +0.4 pp |
| 2019 | 1.1% | €465.00K | €465.00K | €- | €42.66 Million | ▼ -4551.8 pp |
| 2018 | 4552.8% | €56.00K | €56.00K | €- | €1.23K | ▲ +3936.5 pp |
| 2017 | 616.4% | €55.00K | €55.00K | €- | €8.92K | ▲ +201.1 pp |
| 2016 | 415.2% | €68.00K | €68.00K | €- | €16.38K | — |